PMID: 3770062Jan 1, 1986Paper

Plasma concentrations of codeine and its metabolite, morphine, after single and repeated oral administration

European Journal of Clinical Pharmacology
H QuidingP A Hynning

Abstract

Plasma concentrations of codeine and its demethylated metabolite, morphine, were determined after single and repeated oral administration of codeine. Twelve healthy volunteers received two doses of codeine 60 mg, 2.8 h apart. In order to achieve steady-state conditions codeine 60 mg was then taken every 8 h for a further five doses. The plasma concentrations of codeine and morphine after the first, second and seventh doses were analyzed by GC-MS. The maximum plasma concentrations of codeine and morphine were reached about 1 h after administration and this time interval did not change on repeated administration. The peak plasma codeine was higher after the second dose of codeine than after the first and the concentration resembled that at steady-state. For morphine, the plasma concentration did not increase significantly after the second dose. Both after a single dose and during steady-state the plasma concentration of morphine was only 2-3% of that of codeine. It seems unlikely that morphine plays a significant role in the analgesic efficacy of single or repeated doses of codeine.

References

Jun 20, 1977·JAMA : the Journal of the American Medical Association·C M Gruber
Jul 1, 1978·Clinical Pharmacology and Therapeutics·J W FindlayR M Welch
Oct 1, 1977·Clinical Pharmacology and Therapeutics·J W FindlayR M Welch
Jan 1, 1975·Drug Metabolism Reviews·U Boerner
Sep 1, 1971·The Tohoku Journal of Experimental Medicine·K ShimomuraH Tsukamoto
Jan 1, 1984·Journal of Clinical Pharmacology·H QuidingA M Sjöblad
Aug 1, 1982·Clinical Pharmacology and Therapeutics·J F RogersR M Welch

❮ Previous
Next ❯

Citations

Aug 1, 1990·Journal of Clinical Pharmacology·J C Shah, W D Mason
Sep 1, 1993·Journal of Clinical Pharmacology·S S MohammedH Derendorf
Sep 1, 1994·Journal of Clinical Pharmacology·D G May
Jan 1, 1991·European Journal of Clinical Pharmacology·J DesmeulesM Magistris
Jan 1, 1991·European Journal of Clinical Pharmacology·A SomogyiZ R Chen
Aug 18, 2012·International Journal of Legal Medicine·H AndresenT Streichert
Nov 1, 1995·Journal of Pain and Symptom Management·H S DhaliwalA C Darke
Dec 1, 1989·British Journal of Clinical Pharmacology·Q Y YueJ Säwe
Nov 23, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Moran ZurArik Dahan
Feb 3, 2007·Expert Opinion on Drug Metabolism & Toxicology·Joseph K Ritter
Mar 23, 2011·Drug Development and Industrial Pharmacy·P DittrichE Roblegg
Jun 11, 2010·Drug Development and Industrial Pharmacy·Eva RobleggAndreas Zimmer
Mar 7, 2013·Drug Metabolism Reviews·Satya Prakash TripathiAbhay T Sangamwar
May 3, 2014·Journal of Pharmaceutical Sciences·Arik DahanJennifer B Dressman
Oct 13, 2007·The Journal of Physiology·Chester A Ray, Jason R Carter
Dec 6, 2011·Forensic Science International : Synergy·Svetlana V KonstantinovaJørg Mørland
Jul 22, 2014·Journal of Forensic Sciences·Kristen J MertzKarl E Williams
Aug 1, 1994·Journal of Pain and Symptom Management·S CharyA C Darke
Sep 28, 2001·British Journal of Anaesthesia·D G WilliamsR F Howard
Aug 3, 2002·European Journal of Clinical Investigation·E Gil BerglundA Rane
Sep 5, 1998·Clinical Pharmacology and Therapeutics·E RasmussenA Rane
Nov 27, 2008·Journal of Cardiovascular Pharmacology·Heike DeisemannClemens Möller
Mar 7, 2007·Clinical Pharmacology and Therapeutics·Andrew A SomogyiJanet K Coller
Jan 1, 1993·Addiction·J Townsend
Jul 7, 2017·Drug Testing and Analysis·Alexandra MaasCornelius Hess
May 15, 2002·Journal of Clinical Psychopharmacology·Leona C FernandesMyroslava K Romach
Jun 13, 2000·Therapeutic Drug Monitoring·E HaffenP R Bechtel
Oct 26, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·D B CookC A Ray
Feb 18, 1994·Journal of Chromatography. B, Biomedical Applications·M PawulaD A Barrett

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.